Table: Ono Pharm -Q1 group results (IFRS)

ONO PHARMACEUTICAL

31/07/2020 04:00

Jul 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               74.91               73.98           303.00    
                   (+1.3 pct)          (+3.8 pct)       (+3.6 pct)  
  Operating           27.04               19.98            80.00    
                   (+35.3 pct)         (+11.1 pct)      (+3.2 pct)  
  Pretax              28.31               21.20            82.00    
                   (+33.5 pct)         (+9.1 pct)       (+2.9 pct)  
  Net                 21.50               16.33            61.00    
                   (+31.6 pct)         (+7.2 pct)       (+2.2 pct)  
  EPS Basic         43.07 yen           31.84 yen       121.04 yen  
  EPS Diluted       43.06 yen           31.84 yen                   
  Ann Div                               45.00 yen        45.00 yen  
  -Q2 Div                               22.50 yen        22.50 yen  
  -Q4 Div                               22.50 yen        22.50 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T